Financial statements Gemini Pharm
Cash flow statement of Gemini Pharm
Company age:
Age:
9 y. 11 m. 30 d.
Share capital:
Share capital:
5 000 PLN
Cash inflows of GEMINI PHARM
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Net cash from operating expenses | 229 460,66 | 6 489 546,35 | 18 888 286,44 | 15 328 075,20 |
| Net cash flow from investing activities | -309 866,18 | -223 086,93 | -457 624,90 | -10 453 949,10 |
| Net cash flow from financial activities | 184 170,72 | -1 088 652,32 | -8 049 610,66 | -3 441 430,46 |
| Total net cash flow | 103 765,20 | 5 177 807,10 | 10 381 050,88 | 1 432 695,64 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.